home / stock / sln / sln articles
Silence Therapeutics Plc (NASDAQ: SLN) reported a loss for 2023 on Wednesday. The company reported a loss per share of (38.9) pence for 2023, narro...
Silence Therapeutics Plc (NASDAQ:SLN) shares are trading lower in the morning session on Wednesday. The company reported a loss per share of (...
U.S. stocks traded mostly lower, with the Nasdaq Composite falling over 200 points on Wednesday. Shares of The Boeing Company (NYSE: BA) rose duri...
Earlier today, Silence Therapeutics plc (NASDAQ: SLN) announced topline results from the multiple-dose component of the APOLLO phase 1 st...
News, Short Squeeze, Breakout and More Instantly...
Silence Therapeutics Plc Company Name:
SLN Stock Symbol:
NASDAQ Market:
Published findings demonstrate zerlasiran was well-tolerated and significantly reduced Lp(a) after single and multiple dosing Silence Therapeutics plc, Nasdaq: SLN (“Silence” or the “Company”), an experienced and innovative biotechnology company committed to ...
Silence Therapeutics Plc (NASDAQ: SLN) reported a loss for 2023 on Wednesday. The company reported a loss per share of (38.9) pence for 2023, narro...